Datasea (Nasdaq:DTSS) announced progress on R&D efforts related to its brain-computer interface (BCI) technologies.

Subsense announced that it added $10 million in new capital to support its nanoparticle-based brain-computer interface (BCI) ...

A Dexcom (NSDQ:DXCM) communication on its website states that it will soon cease manufacturing for its G6 continuous glucose ...

Salmon retired from Medtronic in September after a more than 20-year tenure at the medtech giant. Most recently, Salmon ...

ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...

Johnson & Johnson MedTech will be one of several companies set to benefit from a new CMS decision related to pulsed field ...

Brain-computer interface (BCI) company Science Corp. announced that it appointed Darius Shahida as its new chief strategy ...

Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

Neurovalens announced that it received FDA de novo approval for Modius Lean, its non-invasive neurotechnology for weight ...

GE HealthCare (Nasdaq: GEHC) has sent affected customers a letter recommending updated instructions for certain anesthesia ...

Intuitive announced that the FDA cleared its da Vinci single port (SP) surgical robot for use in new types of procedures.

Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous ...